Flavio Luis Dantas Portela

Flavio Luis Dantas Portela

Auto-generated profile, based on publicly available information

Flavio Luis Dantas Portela

Hospital Universitário Getúlio Vargas Manaus Brazil

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2023 in The Journal of Pathology
Verified
Journal Article
Open access
JTJeppe Thagaard
Jeppe Thagaard
GBGlenn Broeckx
Glenn Broeckx
DPDavid B Page
David B Page
CJChowdhury Arif Jahangir
Chowdhury Arif Jahangir
SVSara Verbandt
Sara Verbandt
ESElisabeth Specht Stovgaard
Elisabeth Specht Stovgaard
The clinical significance of the tumor‐immune interaction in breast cancer is now established, and tumor‐infiltrating lymphocytes (TILs) have emerged as predictive and prognostic biomarkers for patients with triple‐negative (estrogen receptor, progesterone receptor, and HER2‐negative) breast cancer and HER2‐positive breast cancer. How computational assessments of TILs might complement manual TIL assessment in trial and daily practices is currently debated. Recent efforts to use machine learning (ML) to automatically evaluate TILs have shown promising results. We review state‐of‐the‐art approaches and identify pitfalls and challenges of automated TIL evaluation by studying the root cause of ML discordances in comparison to manual TIL quantification. We categorize our findings into four main topics: (1) technical slide issues, (2) ML and image analysis aspects, (3) data challenges, and (4) validation issues. The main reason for discordant assessments is the inclusion of false‐positive areas or cells identified by performance on certain tissue patterns or design choices in the computational implementation. To aid the adoption of ML for TIL assessment, we provide an in‐depth discussion of ML and image analysis, including validation issues that need to be considered before reliable computational reporting of TILs can be incorporated into the trial and routine clinical management of patients with triple‐negative breast cancer. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

23 August 2023 in The Journal of Pathology
Verified
Journal Article
Closed access
DPDavid B Page
David B Page
GBGlenn Broeckx
Glenn Broeckx
CJChowdhury Arif Jahangir
Chowdhury Arif Jahangir
SVSara Verbandt
Sara Verbandt
RGRajarsi Gupta
Rajarsi Gupta
ESElisabeth Specht Stovgaard
Elisabeth Specht Stovgaard

17 January 2024 in The Journal of Pathology
Verified
Journal Article
Open access
CJChowdhury Arif Jahangir
Chowdhury Arif Jahangir
DPDavid B Page
David B Page
GBGlenn Broeckx
Glenn Broeckx
CGClaudia A Gonzalez
Claudia A Gonzalez
CBCaoimbhe Burke
Caoimbhe Burke
ARArman Rahman
Arman Rahman
Recent advances in the field of immuno‐oncology have brought transformative changes in the management of cancer patients. The immune profile of tumours has been found to have key value in predicting disease prognosis and treatment response in various cancers. Multiplex immunohistochemistry and immunofluorescence have emerged as potent tools for the simultaneous detection of multiple protein biomarkers in a single tissue section, thereby expanding opportunities for molecular and immune profiling while preserving tissue samples. By establishing the phenotype of individual tumour cells when distributed within a mixed cell population, the identification of clinically relevant biomarkers with high‐throughput multiplex immunophenotyping of tumour samples has great potential to guide appropriate treatment choices. Moreover, the emergence of novel multi‐marker imaging approaches can now provide unprecedented insights into the tumour microenvironment, including the potential interplay between various cell types. However, there are significant challenges to widespread integration of these technologies in daily research and clinical practice. This review addresses the challenges and potential solutions within a structured framework of action from a regulatory and clinical trial perspective. New developments within the field of immunophenotyping using multiplexed tissue imaging platforms and associated digital pathology are also described, with a specific focus on translational implications across different subtypes of cancer. © 2024 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

1 April 2012 in Cirugía Cardiovascular
Verified
Journal Article
Open access
PDF file
MVM. García Vieites
M. García Vieites
LAL. Fernández Arias
L. Fernández Arias
FPF. Portela
F. Portela
JBJ. García Barreiro
J. García Barreiro
JCJ.J. Cuenca
J.J. Cuenca
VBV. Bautista-Hernández
V. Bautista-Hernández
Objetivos: El objetivo del presente estudio es comunicar nuestros resultados con la implementación de un programa de cirugía mínimamente invasiva en pacientes pediátricos y adultos con cardiopatías congénitas-estructurales. Material y métodos Durante 2010 y 2011, intervenimos a 45 pacientes consecutivos (32 mujeres) con una edad media de 15,7 años (rango 7 meses - 80 años) mediante una miniesternotomía inferior. Los diagnósticos preoperatorios fueron comunicación interauricular (CIA) ostium secundum (OS) (n = 33), comunicación interventricular (CIV) (n = 8), canal auriculoventricular (AV) (n = 3), sustitución valvular mitral (n = 1). Se recogieron datos intrahospitalarios y de seguimiento. En los pacientes intervenidos en el año 2010, se estudiaron los resultados cosméticos objetivos y subjetivos, mediante las escalas de Vancouver y PSAS, respectivamente. Resultados: Cuarenta y tres de 45 pacientes (96%) se intervinieron sin complicaciones. En dos casos el procedimiento se reconvirtió a esternotomía media sin incidencias; 42/45 pacientes (93%) fueron extubados en las primeras 8 h del posto-peratorio; 3/45 pacientes (7%) desarrollaron fibrilación auricular (FA). No hubo reoperaciones por ningún motivo, ni infecciones de la herida quirúrgica-mediastinitis. Para un seguimiento medio de 8,4 meses, ningún paciente presenta seudoartrosis ni defectos residuales significativos por ecocardiografía. Los pacientes intervenidos en 2010 (n = 15) presentan una puntuación por la escala de Vancouver igual o inferior a 2 (cercana a piel normal) en 13 casos, y en la de PSAS de 8/10 (siendo 10 el mejor resultado cosmético posible). Conclusiones: La implementación de un programa de cirugía mínimamente invasiva a través de miniesternotomía inferior es posible, con excelentes resultados quirúrgicos y cosméticos. Este abordaje es aplicable, y podría ser de elección, para un amplio espectro de pacientes con cardiopatías congénitas-estructurales.

25 July 2023 in Revista do Hospital Universitário Getúlio Vargas
Verified
Journal Article
Closed access
FPFlávio Luis Dantas Portela
Flávio Luis Dantas Portela
CSCaroline Alfaia Silva
Caroline Alfaia Silva
PSPaula Gomes Soares
Paula Gomes Soares
VVVitor Monteiro Do Val
Vitor Monteiro Do Val
JBJonas Byk
Jonas Byk
MMMaiko Ramos Maia
Maiko Ramos Maia
O ensino da anatomia através da dissecção de cadáveres humanos foi, por séculos, a base pedagógica fundamental para a formação de médicos e outros profissionais de saúde. No entanto, apesar de a prática acompanhar a história da medicina desde seus primórdios, até o presente momento não há, na formação do médico, um foco adequado sobre os aspectos éticos relacionados à realização desse procedimento. Tais questões são complexas e envolvem desde a obtenção do cadáver, seu método de preservação, manuseio diário e posterior descarte adequado. Porém, a questão ética central a ser debatida é se a pessoa cujo corpo será fonte para atividades apresentou consentimento para tal. O presente trabalho tem por finalidade realizar breve revisão da história da dissecção humana, os princípios éticos que cercam o tema, seus potenciais conflitos e aspectos legais sobre a utilização de cadáveres para a formação do profissional de saúde.